CROMBEZ ERIC 1653052 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-29 | 2023-09-27 | 4 | Crombez Eric | EVP AND CHIEF MEDICAL OFFICER | holding | 30512.0 | 0 | 4.27 | 0.0 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | NA | 71.49 (RARE) | ||
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Crombez Eric | EVP AND CHIEF MEDICAL OFFICER | dsp | 1238.0 | 2.47 | 0.15 | 53.76 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code S | 48927.0 | 82.11 (RARE) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Crombez Eric | EVP AND CHIEF MEDICAL OFFICER | acq | 19400.0 | 38.87 | 2.36 | 0.0 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code A | 49912.0 | 82.11 (RARE) |
| 2024-04-19 | 2024-04-18 | 2024-04-18 | 4 | Crombez Eric | EVP AND CHIEF MEDICAL OFFICER | dsp | 142.0 | 0.29 | 0.02 | 44.1 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code S | 48785.0 | 82.11 (RARE) |
| 2024-05-03 | 2024-05-02 | 2024-05-02 | 4 | Crombez Eric | EVP AND CHIEF MEDICAL OFFICER | dsp | 354.0 | 0.73 | 0.04 | 43.66 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code S | 48431.0 | 82.11 (RARE) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-29 | 2023-09-27 | 2023-09-27 | 4 | Crombez Eric | EVP AND CHIEF MEDICAL OFFICER | acq | 2351.0 | 100.0 | 0.33 | 67.37 | Direct | Stock Option (Right To Buy) | ULTRAGENYX PHARMACEUTICAL INC. | code A | 2351.0 | 71.49 (RARE) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Crombez Eric | EVP AND CHIEF MEDICAL OFFICER | acq | 36551.0 | 100 | 4.45 | 54.57 | Direct | Stock Option (Right To Buy) | ULTRAGENYX PHARMACEUTICAL INC. | code A | 2351.0
|
82.11 (RARE) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)